Christine Berni Silverstein insider trades: Abeona Therapeutics (ABEO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christine reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | ABEO | ↓ Sell | 18,160 | $5.71 | $104K | Direct | Jun 15, 2026 (0d) |
| Feb 2, 2026 | ABEO | ↓ Sell | 20,070 | $5.09 | $102K | Direct | Feb 4, 2026 (2d) |
| Jul 9, 2025 | ABEO | ↓ Sell | 13,093 | $5.86 | $77K | Direct | Jul 10, 2025 (1d) |
| Jun 18, 2024 | ABEO | ↓ Sell | 25,821 | $4.51 | $116K | Direct | Jun 20, 2024 (2d) |
| Sep 27, 2023 | ABEO | ↓ Sell | 6,330 | $3.91 | $25K | Direct | Sep 29, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ABEO insiders
Open-market trades in the last 12 months
About Christine Berni Silverstein's insider trades
Christine Berni Silverstein is a director at Abeona Therapeutics (ABEO). Since Sep 27, 2023, Christine has reported no open-market purchases and 5 sales worth $424K on SEC Form 4. In the last 12 months: 2 sales ($206K).
Their filings also include grants and awards (15 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ABEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.